Less pain, faster recovery: evaluating 8Fr vs. 22Fr chest tubes in thoracoscopic lung cancer resection.
[PURPOSE] The objective of this study is to compare and analyze the clinical data differences between the use of a single ultra-fine 8Fr chest drainage tube and a single 22Fr conventional chest draina
- p-value P < 0.001
- p-value P = 0.032
APA
Shang Y, Qiu P, et al. (2026). Less pain, faster recovery: evaluating 8Fr vs. 22Fr chest tubes in thoracoscopic lung cancer resection.. Journal of cardiothoracic surgery. https://doi.org/10.1186/s13019-026-03978-1
MLA
Shang Y, et al.. "Less pain, faster recovery: evaluating 8Fr vs. 22Fr chest tubes in thoracoscopic lung cancer resection.." Journal of cardiothoracic surgery, 2026.
PMID
41975473
Abstract
[PURPOSE] The objective of this study is to compare and analyze the clinical data differences between the use of a single ultra-fine 8Fr chest drainage tube and a single 22Fr conventional chest drainage tube, both commonly employed after single-port thoracoscopic lung cancer resection. This comparison aims to evaluate the overall postoperative effectiveness of each method.
[METHODS] We retrospectively analyzed 697 patients undergoing this procedure over two years. After exclusions, 665 patients were categorized: Group A (8Fr tube) and Group B (22Fr tube). Propensity score matching (PSM) was then applied to eliminate confounding factors between the two groups. After PSM, 202 pairs (404 patients) were included in both groups. Outcomes compared included postoperative hospital stay, total drainage volume, pain scores (days 1-3), inflammatory markers, complications, Chronic Postsurgical Pain (CPSP), and quality of life (QOL).
[RESULTS] Group A had significantly lower pain scores on postoperative days 1, 2, and 3 (all P < 0.001), shorter hospital stay (3 [3, 4] vs. 4 [3, 4] days, P = 0.032), and less total drainage volume (180 [130-236.25] ml vs. 255 [170-330] ml, P < 0.001) than Group B. Complication rates and inflammatory markers showed no significant differences (P > 0.05). At one month, Group A reported significantly lower worst/average pain scores (P < 0.001, P = 0.018) and better QOL in activities, mood, work, relationships, and enjoyment (all P < 0.05) compared to Group B. No significant differences existed in mildest pain or walking impact (P > 0.05) or in any pain/QOL measures at 3 months (P > 0.05).
[CONCLUSIONS] Compared to 22Fr tubes, using an 8Fr ultra-fine drain after thoracoscopic lung cancer resection significantly reduces postoperative pain, drainage duration, hospital stay, and total drainage volume. Patients discharged with the 8Fr tube experienced less severe pain and better short-term QOL without increased complications or inflammation. The 8Fr ultra-fine drain is an effective, safe, and clinically valuable alternative.
[METHODS] We retrospectively analyzed 697 patients undergoing this procedure over two years. After exclusions, 665 patients were categorized: Group A (8Fr tube) and Group B (22Fr tube). Propensity score matching (PSM) was then applied to eliminate confounding factors between the two groups. After PSM, 202 pairs (404 patients) were included in both groups. Outcomes compared included postoperative hospital stay, total drainage volume, pain scores (days 1-3), inflammatory markers, complications, Chronic Postsurgical Pain (CPSP), and quality of life (QOL).
[RESULTS] Group A had significantly lower pain scores on postoperative days 1, 2, and 3 (all P < 0.001), shorter hospital stay (3 [3, 4] vs. 4 [3, 4] days, P = 0.032), and less total drainage volume (180 [130-236.25] ml vs. 255 [170-330] ml, P < 0.001) than Group B. Complication rates and inflammatory markers showed no significant differences (P > 0.05). At one month, Group A reported significantly lower worst/average pain scores (P < 0.001, P = 0.018) and better QOL in activities, mood, work, relationships, and enjoyment (all P < 0.05) compared to Group B. No significant differences existed in mildest pain or walking impact (P > 0.05) or in any pain/QOL measures at 3 months (P > 0.05).
[CONCLUSIONS] Compared to 22Fr tubes, using an 8Fr ultra-fine drain after thoracoscopic lung cancer resection significantly reduces postoperative pain, drainage duration, hospital stay, and total drainage volume. Patients discharged with the 8Fr tube experienced less severe pain and better short-term QOL without increased complications or inflammation. The 8Fr ultra-fine drain is an effective, safe, and clinically valuable alternative.
같은 제1저자의 인용 많은 논문 (5)
- BRAF inhibitor resistance in melanoma: from resistance mechanisms to therapeutic innovations.
- Tetrastigma Hemsleyanum Polysaccharide Suppresses Triple-Negative Breast Cancer by Disrupting the Hippo-YAP/TEAD4-PDIA4 Axis and Endoplasmic Reticulum Stress Adaptation.
- Integrated Single-Cell and Bulk RNA Sequencing Identifies SERPING1 as a Biomarker of Immune Infiltration and Prognosis in Triple-Negative Breast Cancer.
- CAPG Regulates Doxorubicin Resistance in Hepatocellular Carcinoma Cells via TGFB1/Smad/Nrf2 Signalling Pathway.
- Vitamin K1 Induced Cytotoxic Effects and Transcriptomic Analysis in Jurkat T Lymphocyte Leukemia Cells.